Super-Resolution STED Microscopy-Based Mobility Studies of the Viral Env Protein at HIV-1 Assembly Sites of Fully Infected T-Cells.
FCS
HIV-1
STED-FCS
microscopy
super-resolution
virus assembly
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
02 04 2021
02 04 2021
Historique:
received:
05
03
2021
revised:
28
03
2021
accepted:
30
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
14
8
2021
Statut:
epublish
Résumé
The ongoing threat of human immunodeficiency virus (HIV-1) requires continued, detailed investigations of its replication cycle, especially when combined with the most physiologically relevant, fully infectious model systems. Here, we demonstrate the application of the combination of stimulated emission depletion (STED) super-resolution microscopy with beam-scanning fluorescence correlation spectroscopy (sSTED-FCS) as a powerful tool for the interrogation of the molecular dynamics of HIV-1 virus assembly on the cell plasma membrane in the context of a fully infectious virus. In this process, HIV-1 envelope glycoprotein (Env) becomes incorporated into the assembling virus by interacting with the nascent Gag structural protein lattice. Molecular dynamics measurements at these distinct cell surface sites require a guiding strategy, for which we have used a two-colour implementation of sSTED-FCS to simultaneously target individual HIV-1 assembly sites via the aggregated Gag signal. We then compare the molecular mobility of Env proteins at the inside and outside of the virus assembly area. Env mobility was shown to be highly reduced at the assembly sites, highlighting the distinct trapping of Env as well as the usefulness of our methodological approach to study the molecular mobility of specifically targeted sites at the plasma membrane, even under high-biosafety conditions.
Identifiants
pubmed: 33918253
pii: v13040608
doi: 10.3390/v13040608
pmc: PMC8067239
pii:
doi:
Substances chimiques
env Gene Products, Human Immunodeficiency Virus
0
gag Gene Products, Human Immunodeficiency Virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MC_UU_12025
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00008/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12010/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12010
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104924/14/Z/14
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0902418
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : MR/K01577X/1
Pays : United Kingdom
Références
Methods. 2015 Oct 15;88:67-75
pubmed: 26123184
Nat Methods. 2015 Sep;12(9):827-30
pubmed: 26214129
Science. 1977 Jan 21;195(4275):305-6
pubmed: 831279
Biophys J. 2015 Feb 3;108(3):596-609
pubmed: 25650927
Nat Commun. 2018 May 10;9(1):1861
pubmed: 29748537
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7
pubmed: 14668432
Science. 2012 Oct 26;338(6106):524-8
pubmed: 23112332
Nat Cell Biol. 2019 Apr;21(4):452-461
pubmed: 30936472
Nat Commun. 2014 Nov 20;5:5412
pubmed: 25410140
Methods. 2018 May 1;140-141:62-73
pubmed: 28963070
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
Cytometry. 1999 Jul 1;36(3):176-82
pubmed: 10404965
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25269-25277
pubmed: 31757854
Nat Commun. 2017 Sep 15;8(1):545
pubmed: 28916807
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):343-8
pubmed: 10618420
Methods. 2018 May 1;140-141:188-197
pubmed: 29258923
Sci Adv. 2019 Oct 02;5(10):eaaw8651
pubmed: 31616784
Nat Rev Mol Cell Biol. 2017 Jun;18(6):361-374
pubmed: 28356571
Biophys J. 2004 Aug;87(2):1260-7
pubmed: 15298928
Nat Rev Microbiol. 2015 Aug;13(8):484-96
pubmed: 26119571
Pathogens. 2020 Nov 21;9(11):
pubmed: 33233482
Nature. 2009 Feb 26;457(7233):1159-62
pubmed: 19098897